Brachytherapy and pancreatic cancer

William R. Bodner, Basil S. Hilaris

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Advances in diagnostic and therapeutic technology have not appreciably changed the outlook of patients with pancreatic cancer. While those patients presenting with localized resectable disease have the best prognosis, local control and intra-abdominal metastases remain significant obstacles to survival. Localized chemoradiation has modestly improved median survival in localized and locally advanced disease. Patients presenting with locally advanced disease at diagnosis benefit from surgical palliation which includes biliary and gastric bypass. Intraoperative interstitial brachytherapy has been effective when utilized at laparotomy to improve local control in locally advanced disease. Advances in laparoscopic techniques have provided the ability to more accurately stage patients prior to laparotomy and perform palliative procedures without the need for laparotomy. The utilization of high-dose-rate brachytherapy has proven effective in palliating obstructive symptoms with minimal morbidity on an outpatient basis. Recent efforts have focused on preoperative chemoradiation to improve resectability in selected patients and prophylactic hepatic irradiation to reduce metastases for patients with locally advanced disease.

Original languageEnglish (US)
Pages (from-to)204-207
Number of pages4
JournalSeminars in Surgical Oncology
Volume13
Issue number3
DOIs
StatePublished - 1997
Externally publishedYes

Fingerprint

Brachytherapy
Pancreatic Neoplasms
Laparotomy
Neoplasm Metastasis
Gastric Bypass
Survival
Outpatients
Technology
Morbidity
Liver

Keywords

  • adjuvant chemotherapy
  • biological tumor markers
  • brachytherapy
  • neoplasm local recurrence
  • neoplasm metastasis
  • pancreatic neoplasms/radiotherapy/surgery
  • radiation dose- response relationship
  • radioisotopes

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Brachytherapy and pancreatic cancer. / Bodner, William R.; Hilaris, Basil S.

In: Seminars in Surgical Oncology, Vol. 13, No. 3, 1997, p. 204-207.

Research output: Contribution to journalArticle

Bodner, William R. ; Hilaris, Basil S. / Brachytherapy and pancreatic cancer. In: Seminars in Surgical Oncology. 1997 ; Vol. 13, No. 3. pp. 204-207.
@article{70dd06be8df24110baa38c3666e4a4a5,
title = "Brachytherapy and pancreatic cancer",
abstract = "Advances in diagnostic and therapeutic technology have not appreciably changed the outlook of patients with pancreatic cancer. While those patients presenting with localized resectable disease have the best prognosis, local control and intra-abdominal metastases remain significant obstacles to survival. Localized chemoradiation has modestly improved median survival in localized and locally advanced disease. Patients presenting with locally advanced disease at diagnosis benefit from surgical palliation which includes biliary and gastric bypass. Intraoperative interstitial brachytherapy has been effective when utilized at laparotomy to improve local control in locally advanced disease. Advances in laparoscopic techniques have provided the ability to more accurately stage patients prior to laparotomy and perform palliative procedures without the need for laparotomy. The utilization of high-dose-rate brachytherapy has proven effective in palliating obstructive symptoms with minimal morbidity on an outpatient basis. Recent efforts have focused on preoperative chemoradiation to improve resectability in selected patients and prophylactic hepatic irradiation to reduce metastases for patients with locally advanced disease.",
keywords = "adjuvant chemotherapy, biological tumor markers, brachytherapy, neoplasm local recurrence, neoplasm metastasis, pancreatic neoplasms/radiotherapy/surgery, radiation dose- response relationship, radioisotopes",
author = "Bodner, {William R.} and Hilaris, {Basil S.}",
year = "1997",
doi = "10.1002/(SICI)1098-2388(199705/06)13:3<204::AID-SSU8>3.0.CO;2-B",
language = "English (US)",
volume = "13",
pages = "204--207",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Brachytherapy and pancreatic cancer

AU - Bodner, William R.

AU - Hilaris, Basil S.

PY - 1997

Y1 - 1997

N2 - Advances in diagnostic and therapeutic technology have not appreciably changed the outlook of patients with pancreatic cancer. While those patients presenting with localized resectable disease have the best prognosis, local control and intra-abdominal metastases remain significant obstacles to survival. Localized chemoradiation has modestly improved median survival in localized and locally advanced disease. Patients presenting with locally advanced disease at diagnosis benefit from surgical palliation which includes biliary and gastric bypass. Intraoperative interstitial brachytherapy has been effective when utilized at laparotomy to improve local control in locally advanced disease. Advances in laparoscopic techniques have provided the ability to more accurately stage patients prior to laparotomy and perform palliative procedures without the need for laparotomy. The utilization of high-dose-rate brachytherapy has proven effective in palliating obstructive symptoms with minimal morbidity on an outpatient basis. Recent efforts have focused on preoperative chemoradiation to improve resectability in selected patients and prophylactic hepatic irradiation to reduce metastases for patients with locally advanced disease.

AB - Advances in diagnostic and therapeutic technology have not appreciably changed the outlook of patients with pancreatic cancer. While those patients presenting with localized resectable disease have the best prognosis, local control and intra-abdominal metastases remain significant obstacles to survival. Localized chemoradiation has modestly improved median survival in localized and locally advanced disease. Patients presenting with locally advanced disease at diagnosis benefit from surgical palliation which includes biliary and gastric bypass. Intraoperative interstitial brachytherapy has been effective when utilized at laparotomy to improve local control in locally advanced disease. Advances in laparoscopic techniques have provided the ability to more accurately stage patients prior to laparotomy and perform palliative procedures without the need for laparotomy. The utilization of high-dose-rate brachytherapy has proven effective in palliating obstructive symptoms with minimal morbidity on an outpatient basis. Recent efforts have focused on preoperative chemoradiation to improve resectability in selected patients and prophylactic hepatic irradiation to reduce metastases for patients with locally advanced disease.

KW - adjuvant chemotherapy

KW - biological tumor markers

KW - brachytherapy

KW - neoplasm local recurrence

KW - neoplasm metastasis

KW - pancreatic neoplasms/radiotherapy/surgery

KW - radiation dose- response relationship

KW - radioisotopes

UR - http://www.scopus.com/inward/record.url?scp=0030992067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030992067&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-2388(199705/06)13:3<204::AID-SSU8>3.0.CO;2-B

DO - 10.1002/(SICI)1098-2388(199705/06)13:3<204::AID-SSU8>3.0.CO;2-B

M3 - Article

C2 - 9143059

AN - SCOPUS:0030992067

VL - 13

SP - 204

EP - 207

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 3

ER -